Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception

Dwi Wanna Jun 21, 2026 0

In a breakthrough that could redefine the landscape of reproductive health, researchers at Cornell University have announced a significant advancement…

Read More
Pharmaceutical R&D

The Dawn of Psychedelics in Medicine: Navigating the Path to Safe and Effective Implementation

Teuku Ryan May 30, 2026 0

The landscape of mental healthcare is on the cusp of a significant transformation with the burgeoning approval of psychedelic-assisted therapies.…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception Through Meiotic Inhibition

Dwi Wanna May 29, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Safe and Reversible Nonhormonal Male Contraceptive Targeting the Meiosis Process

Dwi Wanna Apr 23, 2026 0

In a milestone for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for a…

Read More
Regeneron and CytomX extend cancer therapy partnership to $4bn dealScientists Replicate Human Bone Marrow Complexities in Groundbreaking Lab-Grown ModelOregon State University Researchers Develop Breakthrough Sugar-Coated Nanoparticle Delivery System to Combat Glioblastoma Brain CancerScience News: A Century of Empowering Public Understanding of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ